Canaccord Genuity Group assumed coverage on shares of Hims & Hers Health (NYSE:HIMS – Free Report) in a research report released on Wednesday morning, Benzinga reports. The brokerage issued a buy rating and a $20.00 price objective on the stock. HIMS has been the topic of a number of other research reports. Truist Financial increased […]
Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report)’s stock price fell 2.2% during trading on Thursday . The company traded as low as $15.17 and last traded at $15.17. 624,017 shares changed hands during trading, a decline of 87% from the average session volume of 4,623,425 shares. The stock had previously closed at […]